Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218


Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).

Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL.

Trials. 2011 Mar 15;12:78. doi: 10.1186/1745-6215-12-78.


Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.

Huddart RA, Birtle A, Maynard L, Beresford M, Blazeby J, Donovan J, Kelly JD, Kirkbank T, McLaren DB, Mead G, Moynihan C, Persad R, Scrase C, Lewis R, Hall E.

BJU Int. 2017 Nov;120(5):639-650. doi: 10.1111/bju.13900. Epub 2017 May 29.


Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.

Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC.

Control Clin Trials. 2003 Jun;24(3):272-82.


Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionals.

Lawton J, Snowdon C, Morrow S, Norman JE, Denison FC, Hallowell N.

Trials. 2016 Apr 11;17:195. doi: 10.1186/s13063-016-1323-3.


Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy).

Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A; Published on behalf of the BOLERO Trial Management Group (TMG).

Trials. 2016 Jan 19;17:35. doi: 10.1186/s13063-016-1173-z.


Exploring non-participation in primary care physical activity interventions: PACE-UP trial interview findings.

Normansell R, Holmes R, Victor C, Cook DG, Kerry S, Iliffe S, Ussher M, Fox-Rushby J, Whincup P, Harris T.

Trials. 2016 Apr 1;17:178. doi: 10.1186/s13063-016-1299-z.


Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W.

Eur Urol. 2014 Jul;66(1):120-37. doi: 10.1016/j.eururo.2014.02.038. Epub 2014 Feb 26. Review.


Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.

Rooshenas L, Elliott D, Wade J, Jepson M, Paramasivan S, Strong S, Wilson C, Beard D, Blazeby JM, Birtle A, Halliday A, Rogers CA, Stein R, Donovan JL; ACST-2 study group; By-Band-Sleeve study group; Chemorad study group; CSAW study group; Optima prelim study group; POUT study group.

PLoS Med. 2016 Oct 18;13(10):e1002147. doi: 10.1371/journal.pmed.1002147. eCollection 2016 Oct.


Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.


Involving South Asian patients in clinical trials.

Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P.

Health Technol Assess. 2004 Oct;8(42):iii, 1-109. Review.


Exploring recruitment barriers and facilitators in early cancer detection trials: the use of pre-trial focus groups.

das Nair R, Orr KS, Vedhara K, Kendrick D.

Trials. 2014 Mar 29;15:98. doi: 10.1186/1745-6215-15-98.


A systematic review of training programmes for recruiters to randomised controlled trials.

Townsend D, Mills N, Savović J, Donovan JL.

Trials. 2015 Sep 28;16:432. doi: 10.1186/s13063-015-0908-6. Review.


Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed.

Huddart RA, Hall E, Lewis R, Birtle A; SPARE Trial Management Group.

BJU Int. 2010 Sep;106(6):753-5. doi: 10.1111/j.1464-410X.2010.09537.x. Epub 2010 Jul 26. No abstract available.


Social validity of randomised controlled trials in health services research and intellectual disabilities: a qualitative exploration of stakeholder views.

Robotham D, King M, Canagasabey A, Inchley-Mort S, Hassiotis A.

Trials. 2011 Jun 9;12:144. doi: 10.1186/1745-6215-12-144.


Study of cohort-specific consent and patient control in phase I cancer trials.

Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler M.

J Clin Oncol. 1998 Jul;16(7):2305-12.


Exploring attitudes towards a randomised controlled trial of venous access devices – a nested pre-trial qualitative study.

Ritchie M, Kelly LJ, Moss J, Paul J, Shaw R.

J Vasc Access. 2015 Sep-Oct;16(5):407-12. doi: 10.5301/jva.5000447. Epub 2015 Aug 31.


Supplemental Content

Support Center